Concurrent medications may interfere with tirzepatide's mechanisms
Huberman remains cautious, urging more long-term human trials to assess its overall impact on health span and aging
Additionally, factors related to clinical treatmentsuch as the type of GLP-1RAs, dosage, combination therapy, and duration of treatmenthave exhibited diverse impacts with respect to cancer risk
Frequently Asked Questions Do I have to stop my GLP-1 injection before surgery
Thus, these in vitro findings indicate that the beneficial effect of incretin receptor agonists on fibrosis progression in MASLD patients is likely to be mediated indirectly through improvements in body weight, inflammation, and insulin resistance, rather than through the direct action on hepatic parenchymal or non-parenchymal cells